Alan A. Musso - 26 Jan 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Financial Officer
Signature
/s/ Alan Musso
Issuer symbol
FULC
Transactions as of
26 Jan 2024
Net transactions value
$0
Form type
4
Filing time
30 Jan 2024, 21:05:10 UTC
Previous filing
19 Jan 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 26 Jan 2024 Common Stock 100,000 $6.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.